We are developing novel therapies and groundbreaking early diagnostics for the hundreds of millions of people in underserved populations worldwide who endure painful diseases with no treatment options — and have no voice in their own care.
Real-world experiences from
patients and medical practitioners
drive the development of our
first-in-class healthcare technologies.
A pipeline of synergistic, highly differentiated diagnostic and drug candidates leveraging our novel cellular metabolism approach.
pipeline
A single dose therapy that
inhibits fibrotic tissue growth at
the surgical site.
Learn more
A panel of biomarker tests that
result in earlier detection, enabling early-stage treatment.
Learn more
Our non-invasive biomarker test detects ovarian tumors at earlier stages, promoting better outcomes.
Learn more
We see health and wellness from the patient's perspective. That’s why we’re developing holistic treatments to detect and treat disease while nurturing overall wellbeing. Our goal? To break through the disparities that exist across gender, race, culture, and geography as we deliver the care and compassion you deserve.
Register to receive the latest news and insights from Temple Therapeutics.
